These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
211 related items for PubMed ID: 8105668
1. Long-term trend of decreasing frequency of hepatitis B virus infection. Senba M, Nakamura T, Senba MI, Watanabe M, Zhong X, Itakura H. Acta Virol; 1993; 37(2-3):199-201. PubMed ID: 8105668 [Abstract] [Full Text] [Related]
2. Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands. Munehisa T, Nakata K, Fukahori A, Muro T, Kono K, Furukawa R, Kusumoto Y, Iwanaga A, Ishii N, Koji T. Am J Gastroenterol; 1984 Aug; 79(8):633-6. PubMed ID: 6087656 [Abstract] [Full Text] [Related]
3. [Immunohistochemical studies on the association between hepatitis B surface antigen and primary hepatocellular carcinoma (author's transl)]. Volc-Platzer B, Hanak H, Weiss W, Denk H. Wien Klin Wochenschr; 1982 Feb 19; 94(4):108-14. PubMed ID: 6281995 [Abstract] [Full Text] [Related]
4. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya. Mwangi J, Gatei DG. East Afr Med J; 1993 Apr 19; 70(4 Suppl):34-6. PubMed ID: 8223308 [Abstract] [Full Text] [Related]
5. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India--an autopsy study. Sundaram C, Reddy CR, Ramana GV, Benerjea S, Venkataratnam G, Kumari GS, Reddy BS, Bhaskaran CS. Indian J Pathol Microbiol; 1990 Oct 19; 33(4):334-8. PubMed ID: 1966741 [Abstract] [Full Text] [Related]
6. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K, Pal NS, Arora SK. Indian J Pathol Microbiol; 2006 Jul 19; 49(3):357-61. PubMed ID: 17001884 [Abstract] [Full Text] [Related]
7. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia. Swenson PD, Escobar MR, Silverman JF. Acta Biol Acad Sci Hung; 1980 Jul 19; 31(1-3):321-8. PubMed ID: 6261496 [Abstract] [Full Text] [Related]
8. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies. Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP. Int J Infect Dis; 2008 Nov 19; 12(6):e71-6. PubMed ID: 18658001 [Abstract] [Full Text] [Related]
9. Association of hepatitis B virus with chronic liver diseases and hepatocellular carcinoma. Pati S, Patnaik S, Chawda S, Nanda BK. Indian J Pathol Microbiol; 1989 Apr 19; 32(2):122-4. PubMed ID: 2553594 [Abstract] [Full Text] [Related]
10. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ. J Natl Cancer Inst; 2009 Jul 15; 101(14):1019-27. PubMed ID: 19535774 [Abstract] [Full Text] [Related]
11. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T. Anticancer Res; 2001 Jul 15; 21(4B):2937-40. PubMed ID: 11712790 [Abstract] [Full Text] [Related]
12. Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases. Sakurai M, Miyaji T. Acta Hepatogastroenterol (Stuttg); 1977 Oct 15; 24(5):334-9. PubMed ID: 73335 [Abstract] [Full Text] [Related]
13. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S, Nakashima Y, Kojiro M, Tabor E. J Viral Hepat; 2005 May 15; 12(3):325-9. PubMed ID: 15850475 [Abstract] [Full Text] [Related]
14. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Scand J Gastroenterol; 2008 May 15; 43(7):849-56. PubMed ID: 18584524 [Abstract] [Full Text] [Related]
15. Liver cell dysplasia in liver cirrhosis and hepatocellular carcinoma. Szczepański W. Pol J Pathol; 1997 May 15; 48(3):147-57. PubMed ID: 9401407 [Abstract] [Full Text] [Related]
16. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state. Feinman SV, Berris B, Cooter N, Sinclair JC, Wrobel DM. Hepatogastroenterology; 1982 Apr 15; 29(2):58-61. PubMed ID: 7084885 [Abstract] [Full Text] [Related]
17. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis. Espinoza CG, Pillarisetti SG, Azar HA. Ann Clin Lab Sci; 1984 Apr 15; 14(6):467-73. PubMed ID: 6210034 [Abstract] [Full Text] [Related]
18. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP). Am J Gastroenterol; 2002 Nov 15; 97(11):2886-95. PubMed ID: 12425564 [Abstract] [Full Text] [Related]
19. Significance of hepatitis B surface antigen carriers in a cohort. Iijima T, Nambu M. Trop Gastroenterol; 1988 Nov 15; 9(4):196-8. PubMed ID: 2851885 [No Abstract] [Full Text] [Related]
20. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Cancer; 1999 May 15; 85(10):2132-7. PubMed ID: 10326690 [Abstract] [Full Text] [Related] Page: [Next] [New Search]